USFDA nod to Pfizer Paxlovid for adult patients at high risk of progression to severe COVID 19 Ruchika Sharma26 May 2023 1:30 PM ISTPAXLOVID is a SARS-CoV-2 main protease (Mpro) inhibitor (also known as SARS-CoV-2 3CL protease inhibitor) therapy.
COVID drug: Zenara Pharma unveils generic of Pfizer Paxlovid at Rs 5,200 per box in India Ruchika Sharma10 Sept 2022 9:30 AM ISTThe tablet which will be sold under the brand name Paxzen.
Zenara Pharma gets CDSCO nod to make generic version of Pfizer Covid pill Rahul Verma29 July 2022 6:08 PM ISTHyderabad-based Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, has announced that it has received approval from the...
Biophore India Pharma arm gets CDSCO nod to manufacture, sell generic version of Pfizer COVID drug Paxlovid Ruchika Sharma28 July 2022 12:32 PM ISTIt was the first oral pill that has been approved by USFDA and with a better safety profile than subsequently approved oral therapies.
First: Beximco Pharma launches generic version of Pfizer Paxlovid for COVID treatment Ruchika Sharma31 Dec 2021 3:26 PM ISTThe company will market the product under the brand name Bexovid.
Aurobindo Pharma gets USFDA nod for anti-HIV tablets savita thakur thakur29 Feb 2016 9:22 AM ISTNew Delhi: Drug firm Aurobindo Pharma has received tentative approval from the US health regulator for its Ritonavir tablets used for treatment of...
